TNSN07482A1 - NOVEL INJECTABLE COMPOSITIONS AND PROCESS FOR THE PREPARATION OF SAID COMPOSITIONS - Google Patents

NOVEL INJECTABLE COMPOSITIONS AND PROCESS FOR THE PREPARATION OF SAID COMPOSITIONS

Info

Publication number
TNSN07482A1
TNSN07482A1 TNP2007000482A TNSN07482A TNSN07482A1 TN SN07482 A1 TNSN07482 A1 TN SN07482A1 TN P2007000482 A TNP2007000482 A TN P2007000482A TN SN07482 A TNSN07482 A TN SN07482A TN SN07482 A1 TNSN07482 A1 TN SN07482A1
Authority
TN
Tunisia
Prior art keywords
pain
compositions
conditions
inflammatory
cox
Prior art date
Application number
TNP2007000482A
Other languages
French (fr)
Inventor
Rajesh Jain
Kour Chand Jindal
Sukhjeet Singh
Sanjay Boldhane
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Publication of TNSN07482A1 publication Critical patent/TNSN07482A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne des compositions pharmaceutiques injectables, nouvelles et hautement stables, qui comprennent au moins un inhibiteur de la cyclooxygénase-II (COX-II) ou un anti-inflammatoire non stéroïdien (AINS) ou un inhibiteur de COX/LOX ou leurs formes tautomères, analogues, isomères, polymorphes, solvates, promédicaments ou sels de ces derniers comme principe actif approprié à une administration parentérale, de préférence, par voie intramusculaire (IM) ou intraveineuse (IV). L'invention concerne également un procédé de préparation de ces compositions et des méthodes thérapeutiques d'utilisation de ces compositions. Les compositions injectables analgésiques et anti-inflammatoires selon l'invention sont très utiles chez les mammifères, notamment les humains, pour le traitement d'états douloureux aigus tels qu'un ou plusieurs des états suivants : traumatismes postopératoires, douleur associée au cancer, blessures de sport, migraine, douleur neurologique et douleur associée à la sciatique et à la spondylarthrite et à des maladies analogues et/ou des états de douleur chronique et/ou divers états inflammatoires douloureux, tels que la douleur postopératoire, la dysménorrhée primaire et l'arthrose douloureuse, et/ou d'autres troubles associés, tels que l'inflammation, la fièvre, l'allergie ou des états analogues.Novel and highly stable injectable pharmaceutical compositions comprising at least one cyclooxygenase-II (COX-II) inhibitor or non-steroidal anti-inflammatory drug (NSAID) or COX / LOX inhibitor or forms thereof are provided. tautomers, analogs, isomers, polymorphs, solvates, prodrugs or salts thereof as an active ingredient suitable for parenteral administration, preferably, intramuscularly (IM) or intravenously (IV). The invention also relates to a process for the preparation of these compositions and to therapeutic methods for using these compositions. The injectable analgesic and anti-inflammatory compositions according to the invention are very useful in mammals, in particular humans, for the treatment of acute pain states such as one or more of the following states: postoperative traumas, cancer-related pain, wounds sports, migraine, neurological pain and pain associated with sciatica and spondyloarthritis and similar diseases and / or chronic pain conditions and / or various painful inflammatory conditions, such as postoperative pain, primary dysmenorrhea and painful osteoarthritis, and / or other associated disorders, such as inflammation, fever, allergy or similar conditions.

TNP2007000482A 2005-05-27 2007-12-21 NOVEL INJECTABLE COMPOSITIONS AND PROCESS FOR THE PREPARATION OF SAID COMPOSITIONS TNSN07482A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1357DE2005 2005-05-27
PCT/IN2006/000177 WO2006126214A2 (en) 2005-05-27 2006-05-25 Injectable compositions and process for preparation of such compositions

Publications (1)

Publication Number Publication Date
TNSN07482A1 true TNSN07482A1 (en) 2009-03-17

Family

ID=36917368

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2007000482A TNSN07482A1 (en) 2005-05-27 2007-12-21 NOVEL INJECTABLE COMPOSITIONS AND PROCESS FOR THE PREPARATION OF SAID COMPOSITIONS

Country Status (15)

Country Link
EP (1) EP1895983A2 (en)
JP (1) JP2008542260A (en)
KR (1) KR20080016689A (en)
CN (1) CN101217939A (en)
AU (1) AU2006250765A1 (en)
BR (1) BRPI0611170A2 (en)
CA (1) CA2609242A1 (en)
CR (1) CR9616A (en)
EA (1) EA200702646A1 (en)
MX (1) MX2007014862A (en)
NO (1) NO20076468L (en)
RS (1) RS20070461A (en)
TN (1) TNSN07482A1 (en)
WO (1) WO2006126214A2 (en)
ZA (1) ZA200711068B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103181893A (en) 2007-09-07 2013-07-03 联合治疗公司 Buffer solutionsha ving selective bactericidal activity against gramnegative bacteria and methods of using same
ES2823249T3 (en) 2009-03-12 2021-05-06 Cumberland Pharmaceuticals Inc Ibuprofen administration intravenously
US8871810B2 (en) 2009-07-15 2014-10-28 Cumberland Pharmaceuticals Inc. Treating critically ill patients with intravenous ibuprofen
CN102335114B (en) * 2010-07-23 2015-07-15 重庆医药工业研究院有限责任公司 Stable ibuprofen arginine injection and preparation method thereof
CN102370615B (en) * 2010-08-19 2013-09-04 四川科伦药物研究有限公司 Ibuprofen injection preparation and preparation method thereof
MX2014004566A (en) 2011-10-18 2014-07-09 Raqualia Pharma Inc Medicinal composition.
CN102512383A (en) * 2011-12-25 2012-06-27 天津市嵩锐医药科技有限公司 Parecoxib sodium pharmaceutical composition for injection
US9072710B2 (en) 2012-03-16 2015-07-07 Cumberland Pharmaceuticals Inc. Injectable ibuprofen formulation
CN103372216B (en) * 2012-04-26 2015-05-06 北京京卫燕康药物研究所有限公司 Solid medical composition containing celecoxib
TWI646091B (en) 2012-12-28 2019-01-01 日商衛斯克慧特股份有限公司 Salt and crystal form
US20140187635A1 (en) 2012-12-28 2014-07-03 Themis Medicare Limited Diclofenac compositions
US20140275261A1 (en) 2013-03-15 2014-09-18 Dr. Reddy's Laboratories, Inc. Diclofenac parenteral compositions
CN103263385B (en) * 2013-05-17 2016-04-27 江苏正大清江制药有限公司 A kind of celecoxib long-acing nano injection and preparation method thereof
SG11201704435PA (en) * 2014-12-20 2017-06-29 Troikaa Pharmaceuticals Ltd Injectable formulations of paracetamol
WO2016170401A1 (en) * 2015-04-20 2016-10-27 Umedica Laboratories Pvt. Ltd Novel injectable composition of diclofenac sodium
CN107303266B (en) * 2016-04-18 2020-09-08 重庆润泽医药有限公司 Levo-oxiracetam injection and preparation method thereof
CN107303264A (en) * 2016-04-18 2017-10-31 重庆润泽医药有限公司 Non-foam levo-oxiracetam parenteral solution and preparation method thereof
FR3077984B1 (en) * 2018-02-16 2020-02-21 Vetoquinol Sa MULTI-PURPOSE COMPOSITION OF TORASEMIDE
CN109498852B (en) * 2018-12-29 2022-06-24 广州噢斯荣医药技术有限公司 Biodegradable material for treating orthopedic diseases and application thereof
CN111103381A (en) * 2019-12-25 2020-05-05 南京希麦迪医药科技有限公司 Method for determining nimesulide concentration in human plasma by liquid chromatography-mass spectrometry

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5389681A (en) * 1992-10-22 1995-02-14 Ciba-Geigy Corporation Parenteral solutions for diclofenac salts
IT1283252B1 (en) * 1996-03-15 1998-04-16 Pulitzer Italiana SOLUTIONS OF PIROXICAM INJECTABLE BY PARENTERAL WAY
IN187306B (en) * 1998-01-12 2002-03-23 Panacea Biotec Ltd
MY137736A (en) * 2001-04-03 2009-03-31 Pharmacia Corp Reconstitutable parenteral composition
AU2003249510A1 (en) * 2002-08-12 2004-02-25 Ranbaxy Laboratories Limited A parenteral dosage form of selective cox-2 inhibitors

Also Published As

Publication number Publication date
EP1895983A2 (en) 2008-03-12
KR20080016689A (en) 2008-02-21
CN101217939A (en) 2008-07-09
CA2609242A1 (en) 2006-11-30
RS20070461A (en) 2008-11-28
BRPI0611170A2 (en) 2010-08-17
ZA200711068B (en) 2009-03-25
MX2007014862A (en) 2008-02-21
WO2006126214A3 (en) 2007-06-07
AU2006250765A1 (en) 2006-11-30
WO2006126214A2 (en) 2006-11-30
CR9616A (en) 2008-10-30
JP2008542260A (en) 2008-11-27
NO20076468L (en) 2008-02-27
EA200702646A1 (en) 2008-06-30

Similar Documents

Publication Publication Date Title
TNSN07482A1 (en) NOVEL INJECTABLE COMPOSITIONS AND PROCESS FOR THE PREPARATION OF SAID COMPOSITIONS
BR0008060A (en) Cyclooxygenase-2 inhibitory compositions having rapid onset of therapeutic efficacy
UY26977A1 (en) IMIDAZOL COMPOUNDS CONDENSED WITH ARILO OR HETEROARILO AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS
HUP0400183A2 (en) Orally administered dosage forms of gaba analog prodrugs having reduced toxicity
GT200500060A (en) IMIDAZOL COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS
MA32070B1 (en) Fusion-bonded heterocyclic derivatives and methods of use thereof
TNSN99223A1 (en) PHARMACEUTICAL COMPOSITIONS OF CELECOXIB, PROCESSES FOR THEIR PREPARATION AND METHODS OF TREATMENT USING THE SAME
MA26700A1 (en) PHARMACEUTICAL FORMULATIONS OF CONTROLLED RELEASE cGMP PDE-5 INHIBITORS AND PROCESS FOR THEIR PREPARATION.
MA34474B1 (en) AGONISTS OF GPR40
NO20076508L (en) Acycloxycarbamate prodrugs of tranexamic acid and methods of preparation and use thereof
MA28778B1 (en) RISEDRONATE COMPOSITIONS AND METHOD OF USE THEREOF
MA38576A1 (en) Colchicine extended-release formulations and methods of using the same
MA30413B1 (en) NOVEL LOW DOSE PHARMACEUTICAL COMPOSITIONS CONTAINING NIMESULIDE, THEIR PREPARATION AND USE
DE602004020494D1 (en) ANALGETIC COMPOUNDS, THE SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
EA200901237A1 (en) APPLICATION OF DIMIRACETAM IN THE TREATMENT OF CHRONIC PAIN
ATE480229T1 (en) ORAL PHARMACEUTICAL COMPOSITION FOR TREATING A COX-2-MEDIATED DISEASE
RU2007138263A (en) ANTI-INFLAMMATORY COMPOUNDS
CY1111783T1 (en) Combination therapy of lower urinary tract disorders
DE60110185D1 (en) Composition and method for parenteral administration of ibuprofen D, L-, or L-lysinate
MX2019010692A (en) Curcumin compounds and basic amino acids.
BR112023019496A2 (en) 1,3-SUBSTITUTED CYCLOBUTYL DERIVATIVES AND USES THEREOF
EA200500942A1 (en) MEANS FOR TREATING JOINT DISEASES
PA8579701A1 (en) BETA-LACTAMASA INHIBITOR PROFARMACO
MA27157A1 (en) METHOD FOR THE TREATMENT OF BONE CONDITIONS.
WO2020036478A3 (en) Synergistic pharmaceutical composition comprising aceclofenac and betamethasone for the treatment of pain in localised forms of rheumatic illnesses